Eszlari, Nora http://orcid.org/0000-0003-4913-028X
Millinghoffer, Andras
Petschner, Peter
Gonda, Xenia
Baksa, Daniel
Pulay, Attila J.
Réthelyi, János M.
Breen, Gerome http://orcid.org/0000-0003-2053-1792
Deakin, John Francis William http://orcid.org/0000-0002-2750-962X
Antal, Peter
Bagdy, Gyorgy
Juhasz, Gabriella http://orcid.org/0000-0002-5975-4267
Article History
Received: 21 September 2018
Revised: 31 January 2019
Accepted: 13 February 2019
First Online: 18 March 2019
Conflict of interest
: J.F.W.D. has share options in P1vital, and he has performed research, consultancy, and speaking engagements (all fees are paid to the University of Manchester to reimburse them for the time taken) for AstraZeneca, Autifony, Bristol-Myers Squibb, Eli Lilly, Janssen-Cilag, P1vital, Schering Plough, and Servier. The remaining authors declare no conflict of interest.